Challenges with sirolimus experimental data to inform QSP model of post‐transplantation cyclophosphamide regimens
Abstract Dose optimization of sirolimus may further improve outcomes in allogeneic hematopoietic cell transplant (HCT) patients receiving post‐transplantation cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD). Sirolimus exposure-response association studies in HCT patients (i.e., t...
Saved in:
Main Authors: | Ezhilpavai Mohanan (Author), Guofang Shen (Author), Suping Ren (Author), Hsuan‐Hao Fan (Author), Kao Tang Ying Moua (Author), Aleksandra Karolak (Author), Russell C. Rockne (Author), Ryotaro Nakamura (Author), David A. Horne (Author), Christopher G. Kanakry (Author), Donald E. Mager (Author), Jeannine S. McCune (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precision sirolimus dosing in children: The potential for model-informed dosing and novel drug monitoring
by: Guofang Shen, et al.
Published: (2023) -
Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide
by: Sandi L. Navarro, et al.
Published: (2022) -
Pharmacometabonomic association of cyclophosphamide 4‐hydroxylation in hematopoietic cell transplant recipients
by: Jeannine S. McCune, et al.
Published: (2022) -
Optimization of Initial Dose Regimen for Sirolimus in Pediatric Patients With Lymphangioma
by: Xiao Chen, et al.
Published: (2021) -
Life scientists improve QSP model quality and impact
by: Katherine Kudrycki, et al.
Published: (2024)